|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Current Assets | ||||||||||||||||||
| Cash | ||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||
| Advances Paid | ||||||||||||||||||
| Total Current Assets | ||||||||||||||||||
| Equipment, net | ||||||||||||||||||
| Other non-current assets | ||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||
| Current Liabilities | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Related party payable | ||||||||||||||||||
| Total related party payable | ||||||||||||||||||
| Accrued expenses | ||||||||||||||||||
| Note Payable | ||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||
| Common stock $.001 par value; 150,000,000 shares authorized; 16,072,267 shares issued and outstanding as of June 30, 2026 and 16,072,267 shares issued and outstanding as of December 31, 2025 | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| TOTAL SHAREHOLDERS’ EQUITY | ||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||
Loading...
